ストックスクリーナーアプリを入手
0.00
100.00%
-16.50
前日終値:
$16.50
開ける：
$0
24時間の取引高:
0
Relative Volume:
0.00
時価総額：
$159.70M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-100.00%
1か月 パフォーマンス:
-100.00%
6か月 パフォーマンス:
-100.00%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$0.00
$0.00
1週間の範囲:
$0.00
$0.00
52週間の値動き範囲:
$0.00
$23.00
Invizyne Technologies Inc Stock (IZTC) Company Profile
名前
Invizyne Technologies Inc
セクター
電話
(626) - 415 - 1488
住所
750 ROYAL OAKS DR, MONROVIA
IZTC を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
IZTC
Invizyne Technologies Inc
|
0.00 | 159.70M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
450.50 | 113.52B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
493.22 | 52.93B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
300.83 | 39.71B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
585.93 | 35.00B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
255.86 | 26.57B | 3.81B | -644.79M | -669.77M | -6.24 |
Invizyne Technologies Inc (IZTC) 最新ニュース
BNP Paribas Financial Markets Takes Position in Invizyne Technologies Inc. (NASDAQ:IZTC) - Defense World
Citadel Advisors LLC Invests $456,000 in Invizyne Technologies Inc. (NASDAQ:IZTC) - Defense World
Comparing Invizyne Technologies (NASDAQ:IZTC) and Caribou Biosciences (NASDAQ:CRBU) - Defense World
Invizyne Technologies Inc.’s (NASDAQ:IZTC) Lock-Up Period Set To Expire on May 12th - Defense World
Geode Capital Management LLC Makes New Investment in Invizyne Technologies Inc. (NASDAQ:IZTC) - Defense World
Bringing clarity and precision to the cell-free space by introducing exozymes - markets.businessinsider.com
Head-To-Head Contrast: iTeos Therapeutics (NASDAQ:ITOS) & Invizyne Technologies (NASDAQ:IZTC) - Defense World
EXoZymes Inc. Announces Its Latest Initiative BioClick - MarketScreener
Contrasting Invizyne Technologies (NASDAQ:IZTC) and C4 Therapeutics (NASDAQ:CCCC) - Defense World
EXoZymes appoints experienced biomanufacturing executive, Damien Perriman, as CCO - MarketScreener
EXoZymes, Inc. Announces Management Changes -February 21, 2025 at 04:37 pm EST - Marketscreener.com
ExoZymes Inc. appoints new board member and chairman By Investing.com - Investing.com Australia
eXoZymes and MDB Capital Announce Leadership Transition at eXoZymes Inc. - The Manila Times
eXoZymes Inc. Announces Leadership Changes and Rebranding Following Transition from Invizyne Technologies - Nasdaq
EXoZymes Announces Nasdaq Bell Ringing to Commemorate Initial Public Offering - Marketscreener.com
Can This AI-Powered Enzyme Company Transform the Future of Biotech? Nasdaq's Newest IPO Makes Bold Claims - StockTitan
Positive week for Invizyne Technologies, Inc. (NASDAQ:EXOZ) institutional investors who control 42% of the company - Simply Wall St
Institutional investors own a significant stake of 42% in Invizyne Technologies, Inc. (NASDAQ:IZTC) - Yahoo Finance UK
Invizyne Technologies, Inc. will Change its Name to eXoZymes, Inc -February 12, 2025 at 12:00 am EST - Marketscreener.com
Invizyne Technologies, Inc. will Change its Ticker to EXOZ from IZTC -February 12, 2025 at 12:00 am EST - Marketscreener.com
What’s in a Name: Out with Invizyne, In with eXoZymes - Genetic Engineering & Biotechnology News
Rebranding Invizyne to eXoZymes Signifies a Sustainable - GlobeNewswire
Rebranding Invizyne to eXoZymes Signifies a Sustainable Paradigm Shift in Chemical Production Leveraging - EIN News
Invizyne Technologies rebrands as eXoZymes with new ticker EXOZ - MSN
Invizyne announces corporate name change to eXoZymes - MSN
Invizyne Technologies Announces Name Change To EXoZymes - Nasdaq
MDBHMDB Capital Holdings LLC-A Latest Stock News & Market Updates - StockTitan
Invizyne Technologies Changes Name to eXoZymes -February 10, 2025 at 11:31 am EST - Marketscreener.com
Invizyne Technologies rebrands as eXoZymes with new ticker EXOZ By Investing.com - Investing.com Nigeria
Invizyne Technologies Announces Name Change to eXoZymes, Inc. and New Ticker Symbol - GlobeNewswire
Major Biotech Rebrand: Invizyne Becomes eXoZymesStrategic Move in Enzyme Manufacturing Space - Stock Titan
Invizyne technologies CEO Michael Heltzen buys $20,345 in stock - MSN
Invizyne technologies CEO Michael Heltzen buys $20,345 in stock By Investing.com - Investing.com Australia
Investors on Edge! What Invizyne’s Market Entry Means for Biotech’s Future - Jomfruland.net
Invizyne Technologies Inc.'s (NASDAQ:IZTC) Quiet Period To End on December 23rd - MarketBeat
Invizyne Technologies Inc.’s Quiet Period Set To Expire on December 23rd (NASDAQ:IZTC) - Defense World
Invizyne Technologies selected for $2 million project to advance SAF capabilities - Biodiesel Magazine
Invizyne Technologies Inc trading resumes - Nasdaq
MDB Capital Q3: Mayo Clinic Deal, AUM Surges to $28M, Invizyne IPO Success - StockTitan
Invizyne Technologies Completes IPO, Raises $14 Million in Net Proceeds - Defense World
Opening Day: Invizyne Technologies jumps after IPO - Nasdaq
U.S. IPO Weekly Recap: One Micro-Cap Lists And More Enter Pipeline, As Peak Resources Postpones Its IPO - Seeking Alpha
Invizyne Technologies Announces Closing of Initial Public Offering - GlobeNewswire
Invizyne Technologies stock climbs 13% following $15M IPO - MSN
Invizyne’s Nasdaq IPO Marks New Era of Biomanufacturing - GlobeNewswire
Invizyne Technologies prices $15M U.S. IPO - MSN
Invizyne Technologies to Begin Trading on NASDAQ on November 13, 2024 - The Bakersfield Californian
Invizyne Technologies Inc (IZTC) 財務データ
Invizyne Technologies Inc (IZTC) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
Invizyne Technologies Inc (IZTC) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Heltzen Michael | Chief Executive Officer |
Jan 16 '25 |
Buy |
10.72 |
121 |
1,297 |
2,105 |
| Heltzen Michael | Chief Executive Officer |
Nov 15 '24 |
Buy |
11.10 |
1,984 |
22,022 |
1,984 |
1.21%
1.51%
大文字化:
|
ボリューム (24 時間):